Research explores biochemical and practical aspects of recombinant bacterial β-galactosidases, including lactose-free milk, whey, and galactooligosaccharides yield.
According to the International Dairy Federation (IDF), world milk production in 2021 has reached approximately 931 million. According to the National Bureau of Statistics of Kazakhstan, raw milk production in Kazakhstan in 2022 amounted to 3 million 975 thousand tons. Whey and its derivatives are currently being used more and more in innovative ways to produce a range of food products that are higher-quality and have better health effects. They study how these products affect health and cure and prevent diseases like osteoporosis, cancer, and vascular disease. Typically, whey contains 4-6% lactose. The enzyme β-galactosidase can convert lactose into galactooligosaccharides (GOS). This prebiotic is attractive for food ingredients and supplements because specific Lactobacillaceae and Bifidobacterium families and other gut bacteria may selectively eat and digest GOSs for proliferation and activity. GOS reach the colon undamaged due to their stability and resistance to hydrolysis in the GI tract.
The scientific novelty of the project lies in the study of factors affecting hydrolase and transglycosylase activity and the study of galacto-oligosaccharide formation processes with a focus on prebiotic properties. The practical significance of the project lies in the fact that, in the end, a technology for processing milk whey to obtain specific and demanded products will be proposed. The socio-economic effect is in the development of the processing industry, thanks to which raw materials in the form of whey will be processed into more valuable products in demand in the food industry and with export-oriented potential.
The study compares biochemical parameters of recombinant bacterial β-galactosidases and analyzes how galactooligosaccharides affect probiotic microorganism proliferation.
Lactose-utilizing microbe isolates will be obtained. The gene organization of isolated lactose-utilizing bacteria will be determined. Bacterial recombinant -galactosidases will be isolated and purified, and biochemical parameters will be investigated. The hydrolyzing properties of the isolated enzymes will be determined and the substrate specificity of the isolated β-galactosidases will be studied on various substrates. The transglycosylase activity of the obtained β-galactosidases will be studied and the profile of galactooligosaccharide formation will be compared. The prebiotic properties of galactooligosaccharides with different degrees of polymerization will be determined.
Tursunbekova Annelya E. – Researcher ID: HIG-8491-2022,Scopus Author ID: 58131481100, ORCID: 0000-0002-7536-7451)
Akishev Zhiger D. – Researcher ID: N-6206-2017, Scopus Author ID: 56674741700, ORCHID: 0000-0001-9943-1625)
Mussakhmetov Arman S. – Researcher ID: AAQ-9945-2020, ORCID: 0000-0002-6182-3487, Scopus Author ID: 57203751227
Sagynova Malika N. – ResearcherID: ABR-5877-2022, ORCID: 0000-0002-6948-6817, Scopus Author ID: 58189714400
Maduakhasova Arina K. – Researcher ID: JNE-6827-2023, ORCHID: 0009-0005-1460-0802
Auez Madina K. – Researcher ID: GZG-7318-2022 ORCID: 0000-0001-7159-2793
2024 year
The primary screening of isolated microorganisms was carried out according to their ability to hydrolyze bromochlorindolyl-galactopyranoside, and their identification by cultural and morphological characteristics. 19 bacterial isolates were isolated on MRS agar. Screening of isolates on MRS agar with bromochlorindolyl galactopyranoside showed that 6 isolates did not exhibit X-gal hydrolase activity. The species identification of the strains was carried out using molecular genetic methods based on conserved DNA 16S rRNA sequencing loci and the proteomic profile using the MALDI-TOF (Biotyper) method. Based on the results obtained on β-galactosidase activity, 6 strains were selected for further analysis.Their gene organization was determined, and specific primers for the amplification of beta-galactosidase genes were selected.Amplified beta-galactosidase genes in bacterial plasmids were cloned and 6 bacterial strains of beta-galactosidase producers were obtained.